MAM Asset Management to acquire a %52 stake in Alliar for $232m.

Synopsis

MAM Asset Management, full-service asset manager, agreed to acquire a %52 stake in Alliar, a medical laboratory company, for $232m. On November 19, MAM Asset Management has proposed to buy a controlling stake in Alliar. On November 27, shareholders in Alliar accepted a takeover offer from MAM Asset Management.

Principals

target

ALLIAR

bidder

Mam Asset Management

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (1)

gabriel rozenberg

Investor Relations Officer at ALLIAR

Manager

target

Deal

£ 174 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy